Market Overview

Exagen Diagnostics to Present at The Piper Jaffray 30th Annual Heathcare Conference


ALBUQUERQUE, NM and SAN DIEGO, CA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, a leader in autoimmune life sciences, today announced that it will present at the Piper Jaffray 30th Annual Healthcare Conference, which is being held Nov. 27-29 at the Lotte New York Palace in New York.


Ron Rocca, President and CEO, will present an overview of the patented cell-bound complement activation products (CB-CAPs) technology and other recent advances for the AVISE® brand of testing on Wednesday, November 28 at 10:50 a.m. ET. 

About Exagen Diagnostics
Exagen Diagnostics is a commercial stage life sciences company that is patient focused, and discovery driven. Exagen serves patients and healthcare providers across the U.S. in the diagnosis, prognosis, and management of lupus, rheumatoid arthritis, and other autoimmune conditions. By leveraging our patented and validated CB-CAPs technology we can help get to the real cause of a patient's symptoms and guide their journey to improved health. For more information visit, or follow us on Facebook, Twitter, YouTube, LinkedIn, or Instagram.


Investor Contact: 
Kamal Adawi
Chief Financial Officer of Exagen Diagnostics, Inc.

Kamal Adawi
Exagen Diagnostics, Inc.

View Comments and Join the Discussion!

Latest Ratings

CNPRBC CapitalUpgrades34.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.